-
1
-
-
0034530951
-
Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
-
FIT Research Group
-
Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000; 85(11):4118-4124.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, Issue.11
, pp. 4118-4124
-
-
Black, D.M.1
Thompson, D.E.2
Bauer, D.C.3
-
2
-
-
0034530951
-
Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
-
FIT Research Group
-
Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000; 85(11):4118-4124.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, Issue.11
, pp. 4118-4124
-
-
Black, D.M.1
Thompson, D.E.2
Bauer, D.C.3
-
3
-
-
70349190413
-
Current controversies in bisphosphonate therapy
-
3
-
Kamath AF. Current controversies in bisphosphonate therapy. Orthopedics. 2009; 32(7):473. 3.
-
(2009)
Orthopedics
, vol.32
, Issue.7
, pp. 473
-
-
Kamath, A.F.1
-
4
-
-
38749135807
-
An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
-
Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008; 39(2):224-231.
-
(2008)
Injury
, vol.39
, Issue.2
, pp. 224-231
-
-
Kwek, E.B.1
Goh, S.K.2
Koh, J.S.3
Png, M.A.4
Howe, T.S.5
-
5
-
-
67650468390
-
Association of low-energy femoral fractures with prolonged bisphosphonate use: A case control study
-
Lenart BA, Neviaser AS, Lyman S, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009; 20(8):1353-1362.
-
(2009)
Osteoporos Int
, vol.20
, Issue.8
, pp. 1353-1362
-
-
Lenart, B.A.1
Neviaser, A.S.2
Lyman, S.3
-
6
-
-
34147179587
-
Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution
-
DOI 10.1302/0301-620X.89B3.18146
-
Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007; 89(3):349-353. (Pubitemid 46563912)
-
(2007)
Journal of Bone and Joint Surgery - Series B
, vol.89
, Issue.3
, pp. 349-353
-
-
Goh, S.-K.1
Yang, K.Y.2
Koh, J.S.B.3
Wong, M.K.4
Chua, S.Y.5
Chua, D.T.C.6
Howe, T.S.7
-
7
-
-
43049129258
-
Low-energy femoral shaft fractures associated with alendronate use
-
DOI 10.1097/BOT.0b013e318172841c, PII 0000513120080500000011
-
Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008; 22(5):346-350. (Pubitemid 351630250)
-
(2008)
Journal of Orthopaedic Trauma
, vol.22
, Issue.5
, pp. 346-350
-
-
Neviaser, A.S.1
Lane, J.M.2
Lenart, B.A.3
Edobor-Osula, F.4
Lorich, D.G.5
-
8
-
-
67649742849
-
Case reports: Two femoral insufficiency fractures after long-term alendronate therapy
-
Sayed-Noor AS, Sjödén GO. Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res. 2009; 467(7):1921-1926.
-
(2009)
Clin Orthop Relat Res
, vol.467
, Issue.7
, pp. 1921-1926
-
-
Sayed-Noor, A.S.1
Sjödén, G.O.2
-
9
-
-
31144448185
-
Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate
-
Schneider JP. Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics. 2006; 61(1):31-33.
-
(2006)
Geriatrics
, vol.61
, Issue.1
, pp. 31-33
-
-
Schneider, J.P.1
-
10
-
-
62849101632
-
Bisphosphonates and low-impact femoral fractures: Current evidence on alendronate-fracture risk
-
Schneider JP. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Geriatrics. 2009; 64(1):18-23.
-
(2009)
Geriatrics
, vol.64
, Issue.1
, pp. 18-23
-
-
Schneider, J.P.1
-
11
-
-
52949091144
-
Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid
-
Wernecke G, Namduri S, Dicarlo EF, Schneider R, Lane J. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSS J. 2008; 4(2):123-127.
-
(2008)
HSS J
, vol.4
, Issue.2
, pp. 123-127
-
-
Wernecke, G.1
Namduri, S.2
Dicarlo, E.F.3
Schneider, R.4
Lane, J.5
-
12
-
-
70449901284
-
Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy
-
Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009; 91(11):2556-2561.
-
(2009)
J Bone Joint Surg Am
, vol.91
, Issue.11
, pp. 2556-2561
-
-
Capeci, C.M.1
Tejwani, N.C.2
-
13
-
-
67650767002
-
Adverse effects of bisphosphonates: Implications for osteoporosis management
-
Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009; 84(7):632-637.
-
(2009)
Mayo Clin Proc
, vol.84
, Issue.7
, pp. 632-637
-
-
Kennel, K.A.1
Drake, M.T.2
-
14
-
-
69049100051
-
Increasing options for the treatment of osteoporosis
-
Khosla S. Increasing options for the treatment of osteoporosis. N Engl J Med. 2009; 361(8):818-820.
-
(2009)
N Engl J Med
, vol.361
, Issue.8
, pp. 818-820
-
-
Khosla, S.1
-
15
-
-
47549117752
-
More on atypical fractures of the femoral diaphysis
-
DOI 10.1056/NEJMc080861
-
Kwek EB, Koh JS, Howe TS. More on atypical fractures of the femoral diaphysis. N Engl J Med. 2008; 359(3):316-317. (Pubitemid 352008464)
-
(2008)
New England Journal of Medicine
, vol.359
, Issue.3
, pp. 316-317
-
-
Kwek, E.B.K.1
Koh, J.S.B.2
Howe, T.S.3
-
16
-
-
40949099444
-
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
-
DOI 10.1056/NEJMc0707493
-
Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008; 358(12):1304-1306. (Pubitemid 351439247)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.12
, pp. 1304-1306
-
-
Lenart, B.A.1
Lorich, D.G.2
Lane, J.M.3
|